Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biomarkers of systemic treatment response in people with psoriasis: a scoping review.
Corbett M, Ramessur R, Marshall D, Acencio ML, Ostaszewski M, Barbosa IA, Dand N, Di Meglio P, Haddad S, Jensen AHM, Koopmann W, Mahil SK, Rahmatulla S, Rastrick J, Saklatvala J, Weidinger S, Wright K, Eyerich K, Barker JN, Ndlovu M, Conrad C, Skov L, Smith CH; BIOMAP consortium. Corbett M, et al. Among authors: eyerich k. Br J Dermatol. 2022 Oct;187(4):494-506. doi: 10.1111/bjd.21677. Epub 2022 Jul 20. Br J Dermatol. 2022. PMID: 35606928 Free PMC article. Review.
Mutual antagonism of T cells causing psoriasis and atopic eczema.
Eyerich S, Onken AT, Weidinger S, Franke A, Nasorri F, Pennino D, Grosber M, Pfab F, Schmidt-Weber CB, Mempel M, Hein R, Ring J, Cavani A, Eyerich K. Eyerich S, et al. Among authors: eyerich k. N Engl J Med. 2011 Jul 21;365(3):231-8. doi: 10.1056/NEJMoa1104200. N Engl J Med. 2011. PMID: 21774711 Free article. No abstract available.
A novel molecular disease classifier for psoriasis and eczema.
Garzorz-Stark N, Krause L, Lauffer F, Atenhan A, Thomas J, Stark SP, Franz R, Weidinger S, Balato A, Mueller NS, Theis FJ, Ring J, Schmidt-Weber CB, Biedermann T, Eyerich S, Eyerich K. Garzorz-Stark N, et al. Among authors: eyerich s, eyerich k. Exp Dermatol. 2016 Oct;25(10):767-74. doi: 10.1111/exd.13077. Exp Dermatol. 2016. PMID: 27193975
DMARDs in psoriasis: a critical appraisal.
Eyerich K. Eyerich K. J Eur Acad Dermatol Venereol. 2017 Mar;31(3):388. doi: 10.1111/jdv.14162. J Eur Acad Dermatol Venereol. 2017. PMID: 28297165 Review. No abstract available.
Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS).
Thaçi D, Pinter A, Sebastian M, Termeer C, Sticherling M, Gerdes S, Wegner S, Krampe S, Bartz H, Rausch C, Mensch A, Eyerich K. Thaçi D, et al. Among authors: eyerich k. Br J Dermatol. 2020 Aug;183(2):265-275. doi: 10.1111/bjd.18696. Epub 2020 Jan 20. Br J Dermatol. 2020. PMID: 31705526 Clinical Trial.
226 results